| Absorption |
| Blood-Brain Barrier | BBB- | 0.8979 |
| Human Intestinal Absorption | HIA+ | 0.9784 |
| Caco-2 Permeability | Caco2+ | 0.7824 |
| P-glycoprotein Substrate | Non-substrate | 0.7122 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9877 |
| Non-inhibitor | 0.9915 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9031 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6158 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7843 |
| CYP450 2D6 Substrate | Non-substrate | 0.5678 |
| CYP450 3A4 Substrate | Non-substrate | 0.6502 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7274 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9218 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8431 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8562 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8748 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9246 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8909 |
| Non-inhibitor | 0.9395 |
| AMES Toxicity | Non AMES toxic | 0.9037 |
| Carcinogens | Non-carcinogens | 0.8842 |
| Fish Toxicity | Low FHMT | 0.6109 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9653 |
| Honey Bee Toxicity | High HBT | 0.6077 |
| Biodegradation | Not ready biodegradable | 0.7150 |
| Acute Oral Toxicity | III | 0.5130 |
| Carcinogenicity (Three-class) | Non-required | 0.6893 |